<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) June 14, 1999
-------------
GISH BIOMEDICAL, INC.
(Exact name of Registrant as specified in its charter)
California 0-10728 95-3046028
- --------------------------------------------------------------------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No)
2681 Kelvin Avenue, Irvine, California 92715
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (949) 756-5485
--------------
Not Applicable
- --------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
Page 1 of 3
Exhibit Index on Page 3
<PAGE> 2
ITEM 5. OTHER EVENTS
On June 14, 1999, the Company announced the resignation of Jeanne M.
Miller, the Company's Vice President and Chief Financial Officer. Ms. Miller is
resigning for personal and family reasons. The Company's management has
concluded its search for a new chief financial officer and expects to announce
Ms. Miller's successor shortly.
ITEM 7. EXHIBITS
EXHIBIT NO. DESCRIPTION
99.1 Press Release Dated June 14, 1999
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
GISH BIOMEDICAL, INC.
Date: June 25, 1999 By: /s/ JEANNE M. MILLER
--------------------------------
Jeanne M. Miller
Chief Financial Officer
2 of 3
<PAGE> 3
EXHIBIT INDEX
EXHIBIT NO. DESCRIPTION
- ----------- -----------
99.1 Press Release dated June 14, 1999
3 of 3
<PAGE> 1
EXHIBIT 99.1
PRESS RELEASE DATED JUNE 14, 1999
Gish Biomedical Announces Management Change
- -------------------------------------------
IRVINE, Calif.--June 14, 1999--After 17 years of dedicated service, Jeanne M.
Miller, vice president and chief financial officer, Monday announced that she
will be leaving the company for personal and family reasons.
Miller has been active in the search for her replacement and will be available
during the next six months on a part time basis to help in the transition to a
new financial management team.
Miller added, "My part time role at Gish will enable me to enjoy my new family
responsibilities at an important time. I will miss working with Jack Brown and
the entire Gish team and wish the company well on its future course."
Gish management has concluded its search for a new chief financial officer and
expects to announce Miller's successor shortly.
Gish Biomedical designs and manufactures disposable products for use in
cardiovascular, orthopedic and oncology surgical procedures.
- ------------------------------------------------------------------------
Contact:
Gish Biomedical Inc.
Jack W. Brown, 800/938-0531 or 949/756-5485
